Results 61 to 70 of about 51,398 (196)

Brunner's Gland Hamartoma: Masquerading as a Duodenal Mass

Clinical Case Reports, Volume 13, Issue 4, April 2025.
ABSTRACT Brunner's gland hamartoma is a benign mass of the duodenum often asymptomatic in presentation and typically identified endoscopically. Treatment is dependent on how the mass manifests. If asymptomatic, then no treatment is necessary. If there is concern for malignant transformation or obstruction, then treatment is endoscopic or surgical ...
Dirin Ukwade, Sana Hussain, Saaed Ali, Brian Boulay   +3 more
wiley   +1 more source

Experiences and Fundamental Care Needs in Patients With Small Intestinal Neuroendocrine Tumours—An Interview Study in a Surgical Context

Journal of Advanced Nursing, Volume 81, Issue 4, Page 2061-2071, April 2025.
ABSTRACT Aims The study aimed to describe patients' fundamental care needs and their experiences of nursing care, throughout surgical treatment of small intestinal neuroendocrine tumours. Design A qualitative descriptive study was performed. Methods Patients' interviews (n = 19) were conducted in Sweden from May 2021 to January 2022 and analysed using ...
Frida Olsson, Eva Jangland, Katarina Edfeldt   +2 more
wiley   +1 more source

Zollinger-Ellison syndrome: a case report

Zdravniški Vestnik, 2006
Background: Zollinger-Ellison syndrome is the consequence of excessive and autonomous secretion of gastrin from gastrinoma cells. The disease is exceptionally rare and characterized by severe and treatment-resistant peptic disease that can become life ...
Mitja Krajnc, Miro Čokolič
doaj  

Earlier diagnosis of small intestine neuroendocrine tumours (SI‐NETs) through transformation of the South Wales NET service

Journal of Neuroendocrinology, Volume 37, Issue 4, April 2025.
Patients with small intestine neuroendocrine tumours (SI‐NETs) often face considerable delays in diagnosis. The South Wales NET service underwent a nationally commissioned, systematic transformation aimed at improving diagnosis through education and the development of referral networks.
Harriet L. Gould, Kapish Amin, Thanos Karategos, Sarah Abbas, Susannah Olive, Mathoorika Sivananthan, Ayeesha Rela, Harriet Reed, Catherine Powell, Janu Navaratnam, Rwth Ellis‐Owen, Patrick Fielding, Dipanjali Mondal, Steve Kihara, Gethin Williams, Carys Morgan, Justyna Witczak, Julie Cornish, Sarah Gwynne, James Horwood, Jared Torkington, Rachel Hargest, Adam Christian, Michael Davies, James Ansell, Mohid S. Khan   +25 more
wiley   +1 more source

Primary Hepatic Neuroendocrine Carcinoma Associated With Carcinoid Syndrome and Pellagra: A Case Report

Liver International Communications, Volume 6, Issue 1, March 2025.
ABSTRACT Carcinoid tumours are slow‐growing neuroendocrine neoplasms mainly affecting the gastrointestinal tract, the respiratory tree, ovaries and kidneys. Approximately 20% of patients with carcinoid tumour are affected by carcinoid syndrome, characterised by chronic diarrhoea and/or flushing in the presence of systemically elevated levels of ...
Abdelmounem Eltayeb Abdo, Susanna Caminada, Salma Barakat Mudawi, Sami Medani Abd Elwahab, Ahmed Rafei, Christos Vosinakis, Damiano Pizzol, Lee Smith   +7 more
wiley   +1 more source

Unicentric castleman disease complicated by paraneoplastic bronchiolitis obliterans and pemphigus

Respiratory Medicine Case Reports, 2018
Bronchiolitis obliterans (BO) and paraneoplastic pemphigus are rare and ominous complications of Castleman disease. Collectively, these processes have been reported as part of paraneoplastic autoimmune multiorgan syndrome (PAMS), and they can occur in ...
Hassan A. Raza, MD., Brandon T. Nokes, MD., Allison C. Rosenthal, DO., Aaron R. Mangold, MD., Katalin Kelemen, MD., Clinton E. Jokerst, MD., Rodrigo Cartin-Ceba, MD.,MSc.   +6 more
doaj  

Assessment of response to PRRT including anatomical and molecular imaging as well as novel biomarkers

Journal of Neuroendocrinology, Volume 37, Issue 3, March 2025.
Abstract Peptide receptor radionuclide therapy (PRRT) is an effective treatment for both oncological and hormone control and is a widely accepted standard of care treatment for patients with neuroendocrine neoplasms (NEN). Its use is anticipated to increase significantly, and this demands accurate tools and paradigms to assess treatment response post ...
Grace Kong, Geertje Noe, Cherie Chiang, Ken Herrmann, Thomas A. Hope, Michael Michael   +5 more
wiley   +1 more source

Bilateral granulosa cell tumors: a novel malignant manifestation of multiple endocrine neoplasia 1 syndrome found in a patient with a rare menin in-frame deletion

The Application of Clinical Genetics, 2015
Michael J Hall,1 Julie Innocent,2 Christina Rybak,1 Colleen Veloski,3 Walter J Scott,4 Hong Wu,5 John A Ridge,4 John P Hoffman,4 Hossein Borghaei,2 Aruna Turaka,6 Mary B Daly1 1Department of Clinical Genetics, 2Department of Medical Oncology, 3Department
Hall MJ, Innocent J, Rybak C, Veloski C, Scott WJ, Wu H, Ridge JA, Hoffman JP, Borghaei H, Turaka A, Daly MB   +10 more
doaj  

Hypoxemia in Malignant Carcinoid Syndrome: A Case Attributed to Occult Lymphangitic Metastatic Involvement [PDF]

, 1991
Dennis E. Amundson, Peter Weiss
openalex   +1 more source

Malignant Gastric Carcinoid Causing Ectopic ACTH Syndrome: Discrepancy of Plasma ACTH Levels Measured by Different Immunoradiometric Assays

, 2005
Kyoichiro Tsuchiya, Isao Minami, Toru Tateno, Hajime Izumiyama, Masaru Doi, Tetsuo Nemoto, Sunao Mae, Tsutomu Kasuga, R. Yoshiyuki Osamura, Yutaka Oki, Yukio Hirata   +10 more
openalex   +2 more sources